The treatment of infections in general practice with magnapen: a multicentre trial.
This study was carried out in general practice. Six hundred and forty-seven infections of the respiratory tract, urinary tract and the skin and soft tissues in 646 patients were treated with oral Magnapen (250 mg ampicillin + 250 mg flucloxacillin) four times each day. An overall success rate of 94% was achieved. The main side-effect was diarrhoea causing 2.5% of patients to discontinue therapy. These results demonstrate the outstanding value of Magnapen in treating a wide variety of infections in general practice.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D003023:Cloxacillin / Q000031:analogs & derivatives*; D004338:Drug Combinations; D005260:Female; D005436:Floxacillin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D004338:Drug Combinations; D005436:Floxacillin; D000667:Ampicillin; D003023:Cloxacillin